Clinical Trial

Cardiovascular Risk in Patients With Takayasu Arteritis: A Nationwide Population-Based Cohort Study

Study acronym: TAK-CV-2026
Completed
View on ClinicalTrials.gov →
Summary
This nationwide observational cohort study compares the risk of major adverse cardiovascular events (MACE) and territory-specific arterial complications between patients with incident Takayasu arteritis and matched general-population controls, and identifies determinants of MACE within the Takayasu arteritis population, including cumulative glucocorticoid exposure, using the French National Health Data System (SNDS).
Trial Details
NCT Number NCT07686991
Lead Sponsor Groupe français d'étude des Maladies Inflammatoires de loeil
Conditions Takayasu Arteritis, Cardiovascular Diseases
Enrollment 8,275 participants
Start Date 2010-01-01
Primary Completion 2024-12-31 (estimated)
Study Completion 2024-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-07